References
- Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 1981; 152: 765–72
- Lagios M D, Richards V E, Rose M R, Yee E. Segmental mastectomy without radiotherapy. Short-term follow-up. Cancer 1983; 52: 2173–9
- Shukla H S, Gravelle I H, Hughes L E, Newcombe R G, Williams S. Mammary skin oedema: a new prognostic indicator for breast cancer. Br J Med 1984; 288: 1338–41
- Brinkley D, Haybittle J L, Houghton J. The cancer research campaign (King's/Cambridge) trial for early breast cancer: an analysis of the radiotherapy data. Br J Radiol 1984; 57: 309–16
- Host H, Brennhovd IO. The effect of postoperative radiotherapy in breast cancer. Int J Radiat Oncol Biol Phys 1977; 2: 1061–7
- Host H, Brennhovd I O, Loeb M. Postoperative radiotherapy in breast cancer. Long-term results from the Oslo study. Int J Radiat Oncol Biol Phys 1986; 12: 727–32
- Lee Y-TN. Surgical treatment of carcinoma of the breast: III. Pathological findings and probability of relapse. J Surg Oncol 1984; 25: 109–15
- Nixon S J, Steele R JC, Hawkins A R, McGregor J, Forrest A PM. Prediction of recurrence after mastectomy for operable breast cancer. Br J Surg 1985; 72: 7–9
- Atkin NB. Modal DNA value and survival in carcinoma of the breast. Br Med J 1972; 86: 271–2
- Atkin N B, Kay R. Prognostic significance of modal DNA value and other factors in malignant tumours, based on 1 465 cases. Br J Cancer 1979; 40: 210–21
- Philippe E, Le Gal Y. Growth of seventy-eight recurrent mammary cancers. Quantitative study. Cancer 1968; 21: 461–7
- Rutgers E JT h, van Slooten E A, Kluck HM. Follow-up after treatment of primary breast cancer. Br J Surg 1989; 76: 187–90
- Cowan J D, Kies MS. Detection of recurrent breast cancer. South Med J 1981; 74: 910–2
- Charlson ME. Rate of progression in breast cancer and the disease-free interval. Surgery 1985; 97: 397–401
- Lundgren B. The growth rate of breast cancer as a dynamic indicator of prognosis. Australas Radiol 1983; 27: 178–80
- Osteen R T, Connolly J L, Recht A, Silver B, Schnitt S J, Harris JR. Identification of patients at high risk for local recurrence after conservative surgery and radiation therapy for stage I or II breast cancer. Arch Surg 1987; 122: 1248–52
- Rosen P P, Saigo P E, Braun DW, Jr., Weathers E, DePalo A. Predictors of recurrence in stage I (T1 N0 M0) breast carcinoma. Ann Surg 1981; 193: 15–25
- Mueller CB. Stage II breast cancer is not simply a late stage I. Surgery 1988; 104: 631–8
- Lee Y-TN, Chan LS. Surgical treatment of carcinoma of the breast: II. Prognostic factors influencing relapse rate. J Surg Oncol 1984; 25: 102–8
- McCormack P M, Bains M S, Burt M E, Martini N, Chaglassian T, Hidalgo DA. Local recurrent mammary carcinoma failing multimodality therapy. A solution. Arch Surg 1989; 124: 158–61
- Fentiman I S, Matthews P N, Davison O W, Millis R R, Hayward JL. Survival following local skin recurrence after mastectomy. Br J Surg 1985; 72: 14–6
- Chiedozi LC. Prognostic significance of exclusive skeletal metastases in stage IV primary carcinoma of the breast. Surg Gynecol Obstet 1988; 167: 303–6